Search research articles
Contact Us
Filters
Showing results (81-90 of 405) with videos related to
Page
of 41
Sort By:
Indian Journal of Thoracic and Cardiovascular Surgery
|
April 29, 2024
Anesthetic management in a patient with acute aortic dissection and severe left ventricular systolic dysfunction
Chandra Prakash, Malik Indira, Budhwar Deepika, et al.
Journal of Biochemical and Molecular Toxicology
|
February 23, 2017
Protective effect of hydroxytyrosol in arsenic-induced mitochondrial dysfunction in rat brain
Manisha Soni, Chandra Prakash, Sfurti Sehwag, et al.
Epilepsy Research
|
January 4, 2019
Curcumin's antiepileptic effect, and alterations in Na<sub>v</sub>1.1 and Na<sub>v</sub>1.6 expression in iron-induced epilepsy
Vikas Kumar, Chandra Prakash, Rameshwar Singh, et al.
Rapid Communications in Mass Spectrometry : RCM
|
July 31, 2007
Characterization of metabolites of a NK1 receptor antagonist, CJ-11,972, in human liver microsomes and recombinant human CYP isoforms by liquid chromatography/tandem mass spectrometry
Chandra Prakash, Jinyan Lin, Kevin Colizza, et al.
Current Drug Metabolism
|
November 11, 2008
In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery
Chandra Prakash, Raman Sharma, Michelle Gleave, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 22, 2011
Excretion, metabolism, and pharmacokinetics of 1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide, a selective cannabinoid receptor antagonist, in healthy male volunteers
Zhuang Miao, Hao Sun, Jennifer Liras, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 19, 2013
Metabolism and excretion of 6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine, an HSP90 inhibitor, in rats and dogs and assessment of its metabolic profile in plasma of humans
Lin Xu, Caroline Woodward, Jing Dai, et al.
Education and Information Technologies
|
February 23, 2022
Personalized and Adaptive Context-Aware Mobile Learning: Review, challenges and future directions
Chandra Prakash Gumbheer, Kavi Kumar Khedo, Anjali Bungaleea
CPT: Pharmacometrics & Systems Pharmacology
|
April 6, 2021
PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction
Jayaprakasam Bolleddula, Alice Ke, Hua Yang, et al.
Case Reports in Gastroenterology
|
April 14, 2011
Pancreatitis following Olanzapine Therapy: A Report of Three Cases
Thomas A Kerr, Sreenivasa Jonnalagadda, Chandra Prakash, et al.
Page
of 41
Search research articles
Search
Showing results (81-90 of 405) with videos related to
Sort By:
Page
of 41
Indian Journal of Thoracic and Cardiovascular Surgery
|
April 29, 2024
Anesthetic management in a patient with acute aortic dissection and severe left ventricular systolic dysfunction
Chandra Prakash, Malik Indira, Budhwar Deepika, et al.
Journal of Biochemical and Molecular Toxicology
|
February 23, 2017
Protective effect of hydroxytyrosol in arsenic-induced mitochondrial dysfunction in rat brain
Manisha Soni, Chandra Prakash, Sfurti Sehwag, et al.
Epilepsy Research
|
January 4, 2019
Curcumin's antiepileptic effect, and alterations in Na<sub>v</sub>1.1 and Na<sub>v</sub>1.6 expression in iron-induced epilepsy
Vikas Kumar, Chandra Prakash, Rameshwar Singh, et al.
Rapid Communications in Mass Spectrometry : RCM
|
July 31, 2007
Characterization of metabolites of a NK1 receptor antagonist, CJ-11,972, in human liver microsomes and recombinant human CYP isoforms by liquid chromatography/tandem mass spectrometry
Chandra Prakash, Jinyan Lin, Kevin Colizza, et al.
Current Drug Metabolism
|
November 11, 2008
In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery
Chandra Prakash, Raman Sharma, Michelle Gleave, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 22, 2011
Excretion, metabolism, and pharmacokinetics of 1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide, a selective cannabinoid receptor antagonist, in healthy male volunteers
Zhuang Miao, Hao Sun, Jennifer Liras, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 19, 2013
Metabolism and excretion of 6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine, an HSP90 inhibitor, in rats and dogs and assessment of its metabolic profile in plasma of humans
Lin Xu, Caroline Woodward, Jing Dai, et al.
Education and Information Technologies
|
February 23, 2022
Personalized and Adaptive Context-Aware Mobile Learning: Review, challenges and future directions
Chandra Prakash Gumbheer, Kavi Kumar Khedo, Anjali Bungaleea
CPT: Pharmacometrics & Systems Pharmacology
|
April 6, 2021
PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction
Jayaprakasam Bolleddula, Alice Ke, Hua Yang, et al.
Case Reports in Gastroenterology
|
April 14, 2011
Pancreatitis following Olanzapine Therapy: A Report of Three Cases
Thomas A Kerr, Sreenivasa Jonnalagadda, Chandra Prakash, et al.
Page
of 41